Cyber Resilience

CVE-2021-40374

MediumPublic PoC

Published: 06 April 2022

Published
06 April 2022
Modified
21 November 2024
KEV Added
Patch
CVSS Score v3.1 5.4 CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
EPSS Score 0.0191 83.7th percentile
Risk Priority 12 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2021-40374 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Apperta Openeye. Its CVSS base score is 5.4 (Medium).

Operationally, ranked in the top 16.3% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.

EU & UK References

Vulnerability details

A stored cross-site scripting (XSS) vulnerability was identified in Apperta Foundation OpenEyes 3.5.1. Updating a patient's details allows remote attackers to inject arbitrary web script or HTML via the Address1 parameter. This JavaScript then executes when the patient profile is…

more

loaded, which could be used in a XSS attack.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

apperta
openeye
3.5.1

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-79

Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.

addresses: CWE-79

Validates web inputs to reject script-related content that could produce XSS.

addresses: CWE-79

Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.

References